loading...| Preferred Name |
heparin sodium |
|
| Synonyms |
Lipo-Hepin |
|
| Definitions |
The sodium salt form of heparin. As a glycosaminoglycan anticoagulant, heparin sodium binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C833" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C833" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000791439 |
|
| altLabel |
Lipo-Hepin Hep-Lock sodium heparin |
|
| CAS Registry |
9041-08-1 |
|
| cui |
C0700893 C0700892 C0037513 |
|
| DATE FIRST PUBLISHED |
2017-11-28 |
|
| Date last modified |
2017-11-30 |
|
| definition |
The sodium salt form of heparin. As a glycosaminoglycan anticoagulant, heparin sodium binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C833" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C833" NCI Thesaurus) |
|
| LT |
TRD |
|
| NCI ID |
C833 |
|
| notation |
CDR0000791439 |
|
| NSC Code |
145954 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
heparin sodium |
|
| tui |
T109 T121 |